posted
Stocks to Watch for Thursday, December 1, 2005: LFTC -- Lifestream Announces Agreement With GenExel for Production of the New Three-in-One Blood Pressure Monitor! 12/1/05
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by Market Pulse.
ATLANTA, GA, Dec 01, 2005 (MARKET WIRE via COMTEX) -- Market Pulse is pleased to introduce our featured stock, Lifestream Technologies, Inc. (OTC BB: LFTC), to the investment community! Lifestream is new to Market Pulse and is poised to become a significant player in the healthcare industry! LFTC just had excellent news out in a press release before today's opening bell announcing that it has entered into an agreement with GenExel-Sein, Inc., for the production of the new Lifestream three-in-one blood pressure monitor! Investors should be watching this one closely! Other notable stocks that should be watched because they look great lately from a fundamental and technical perspective include:
Microsoft Corp. (NASDAQ: MSFT) : Market Outperform
Loudeye Corp. (NASDAQ: LOUD) : Attractive
Research In Motion Ltd. (NASDAQ: RIMM) : Bearish
Recommendation Meanings
These recommendations are investment opinions of Market-Pulse.com and reflect the stock's potential to move over the next one to four weeks of trading. This analysis is done from a technical and fundamental perspective.
After Wednesday's Bell Market Commentary
On Wednesday, a barrel of light crude settled at $57.32, up 82 cents, on the New York Mercantile Exchange. Despite hurricanes and oil price shocks, the nation's economy managed to grow at a 4.3% pace in the 3rd quarter to beat expectations. The performance was an improvement from 2nd quarter's 3.3% GDP. The markets closed lower as strong economic growth sparked fears that interest rate hikes would continue. The Dow Jones industrial average fell 82.29, or 0.76 percent, to 10,805.87. The Nasdaq composite index rose 0.11, to 2,232.82. The Standard & Poor's 500 index lost 8.00, or 0.64 percent, to 1,249.48. The Russell 2000 index rose 3.60, or 0.53 percent, to 677.29.
-------------------- Trading is a blast!!
IP: Logged |
posted
Investors need to be watching Lifestream Technologies, Inc. (OTC BB: LFTC) this AM! Lifestream develops, markets and sells a line of smart card-enabled healthcare diagnostic devices. Lifestream has developed and currently markets a line of cholesterol monitors that provide test results in three minutes for at-home use by health conscious consumers and at-risk medical patients. Lifestream just had excellent news out in a press release before today's opening bell announcing that it has entered into an agreement with GenExel-Sein, Inc., for the production of the new Lifestream three-in-one blood pressure monitor! This could be great news for investors!
Lifestream Technologies, Inc. (OTC BB: LFTC), a leading supplier of cholesterol monitors, announced today that it has entered into an agreement with GenExel-Sein, Inc., for the production of the new Lifestream Three In One Blood Pressure monitor.
"We are pleased that, after over 6 months of review and discussions with numerous blood pressure manufacturers, GenExel met our stringent quality standards and had the clarity of vision for this market opportunity," stated Christopher Maus, Lifestream's CEO. "This new technology will complement our product line and expand our present market opportunities in an area not yet commercialized."
The new Lifestream "Three-in-One" Blood Pressure monitor will measure blood pressure, cholesterol and HDL, all in less than three minutes. Consumer awareness for cholesterol testing can be significantly expanded through this merger. Between 5 to 7 million blood pressure monitors are sold each year in the U. S. or 14 million worldwide.
"The health conscious consumer, who uses or will use a blood pressure monitor, now has a real clear choice," continued Maus. "This dual use device supplies more meaningful information about a consumer's cardiac health. The combined unit is also more cost effective and will play an essential role for individuals who are managing both blood pressure and cholesterol. There is an estimated 73% overlap of individuals with elevated blood pressure and high cholesterol. About 20 million people are on both blood pressure and cholesterol lowering medications."
"GenExel is pleased to be partnering with Lifestream on this very innovative product," said Dr. Douglas Stafford, Executive Vice President of GenExel. "Lifestream understands the market as much as GenExel does. This collaboration is perfect given that GenExel is also bringing an innovative Blood Pressure/Glucose monitor to the market. This product is a natural evolution for the hypertensive market. Together, Lifestream and GenExel have an opportunity to meet the goals of both companies and give health conscious consumers more quality choices."
About GenExel-Sein, Inc.
GenExel is a rapidly growing medical products company with headquarters in South Korea. Its business units provide innovative products for home medical diagnosis and engage in the discovery and development of pharmaceutical products with an emphasis on central system disorders (such as Alzheimer's disease and Parkinson's disease). The company has operating subsidiaries in South Korea, China, Germany, the United Kingdom, and the United States. It is traded publicly on the KOSDAQ under the symbol GENEXEL. For more information, visit GenExel-Sein online at www.seinbpm.com or www.genexel.com. Contact: GenExel-Sein, Inc., 111 Seocho-Gu, YangJae-1 Dong, Namkyung Bldg 3rd Floor 137-891, Seoul, South Korea, for more information on the company.
-------------------- Trading is a blast!!
IP: Logged |
UBBFriend: Email this page to someone!
Printer-friendly view of this topic
![[Wink]](wink.gif)
